Exact Mass: 525.2396
Exact Mass Matches: 525.2396
Found 179 metabolites which its exact mass value is equals to given mass value 525.2396
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Mikamycin A
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].
virginiamycin m1
Selpercatinib
Chondrochloren A
A monocarboxylic acid amide with formula C27H40ClNO7, that is produced by Chondromyces crocatus and exhibits antibiotic properties.
Tyr Ser Glu Lys
Cys Phe Arg Thr
Cys Phe Thr Arg
Cys Arg Phe Thr
Cys Arg Thr Phe
Cys Thr Phe Arg
Cys Thr Arg Phe
Asp Lys Thr Tyr
Asp Lys Tyr Thr
Asp Thr Lys Tyr
Asp Thr Tyr Lys
Asp Tyr Lys Thr
Asp Tyr Thr Lys
Glu Lys Ser Tyr
Glu Lys Tyr Ser
Glu Ser Lys Tyr
Glu Ser Tyr Lys
Glu Tyr Lys Ser
Glu Tyr Ser Lys
Phe Cys Arg Thr
Phe Cys Thr Arg
Phe Arg Cys Thr
Phe Arg Thr Cys
Phe Thr Cys Arg
Phe Thr Arg Cys
Gly Met Arg Tyr
Gly Met Tyr Arg
Gly Arg Met Tyr
Gly Arg Tyr Met
Gly Tyr Met Arg
Gly Tyr Arg Met
His Pro Ser Trp
His Pro Trp Ser
His Ser Pro Trp
His Ser Trp Pro
His Trp Pro Ser
His Trp Ser Pro
Lys Asp Thr Tyr
Lys Asp Tyr Thr
Lys Glu Ser Tyr
Lys Glu Tyr Ser
Lys Ser Glu Tyr
Lys Ser Tyr Glu
Lys Thr Asp Tyr
Lys Thr Tyr Asp
Lys Tyr Asp Thr
Lys Tyr Glu Ser
Lys Tyr Ser Glu
Lys Tyr Thr Asp
Met Gly Arg Tyr
Met Gly Tyr Arg
Met Arg Gly Tyr
Met Arg Tyr Gly
Met Tyr Gly Arg
Met Tyr Arg Gly
Pro His Ser Trp
Pro His Trp Ser
Pro Ser His Trp
Pro Ser Trp His
Pro Trp His Ser
Pro Trp Ser His
Arg Cys Phe Thr
Arg Cys Thr Phe
Arg Phe Cys Thr
Arg Phe Thr Cys
Arg Gly Met Tyr
Arg Gly Tyr Met
Arg Met Gly Tyr
Arg Met Tyr Gly
Arg Thr Cys Phe
Arg Thr Phe Cys
Arg Tyr Gly Met
Arg Tyr Met Gly
Ser Glu Lys Tyr
Ser Glu Tyr Lys
Ser His Pro Trp
Ser His Trp Pro
Ser Lys Glu Tyr
Ser Lys Tyr Glu
Ser Pro His Trp
Ser Pro Trp His
Ser Trp His Pro
Ser Trp Pro His
Ser Tyr Glu Lys
Ser Tyr Lys Glu
Thr Cys Phe Arg
Thr Cys Arg Phe
Thr Asp Lys Tyr
Thr Asp Tyr Lys
Thr Phe Cys Arg
Thr Phe Arg Cys
Thr Lys Asp Tyr
Thr Lys Tyr Asp
Thr Arg Cys Phe
Thr Arg Phe Cys
Thr Tyr Asp Lys
Thr Tyr Lys Asp
Trp His Pro Ser
Trp His Ser Pro
Trp Pro His Ser
Trp Pro Ser His
Trp Ser His Pro
Trp Ser Pro His
Tyr Asp Lys Thr
Tyr Asp Thr Lys
Tyr Glu Lys Ser
Tyr Glu Ser Lys
Tyr Gly Met Arg
Tyr Gly Arg Met
Tyr Lys Asp Thr
Tyr Lys Glu Ser
Tyr Lys Ser Glu
Tyr Lys Thr Asp
Tyr Met Gly Arg
Tyr Met Arg Gly
Tyr Arg Gly Met
Tyr Arg Met Gly
Tyr Ser Lys Glu
Tyr Thr Asp Lys
Tyr Thr Lys Asp
3,5-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)guanosine
N-(9,9-dimethyl-9H-fluoren-2-yl)-9,9-diphenyl-9H-fluoren-2-amine
N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]glycinamide
(2S,3S,5S)-5-(tert-Butoxycarbonylamino)-2-(N-5-thiazolylmethoxycarbonyl)amino-1,6-diphenyl-3-hydroxyhexane
Sonolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Selpercatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Deptropine citrate
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
Virginiamycin M1
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D025361 - Streptogramins C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic Virginiamycin M1 (Pristinamycin IIA; Ostreogrycin A), produced by?Streptomyces virginiae, is an polyunsaturated macrocyclic lactone antibiotic and acts as a component of Virginiamycin (HY-112665)[1]. Virginiamycin M1 alone is against Staphylococcus aureus with a MIC of 0.25 μg/mL. The combination of Virginiamycin M1 and Virginiamycin S1 (HY-N6680) is 0.125 μg/mL (MIC Value), which can improve the bactericidal effect 1-30 times[2].
[(1-{2[(4-Carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazol-5-YL}-cyclopropyl)-pyridin-2-YL-methyleneaminooxy]-acetic acid ethyl ester
(E,3R,8S,9S,10R)-N-[(Z)-2-(3-chloro-4-hydroxyphenyl)ethenyl]-3,9-dihydroxy-2,4-dimethoxy-6,8,10-trimethyl-7-oxotetradec-5-enamide
[(6Z)-6-[[bis(prop-2-enyl)amino]methylidene]-5-hydroxy-9-(methoxymethyl)-9a,11a-dimethyl-1,4,7-trioxo-2,3,3a,9,10,11-hexahydroindeno[4,5-h]isochromen-10-yl] acetate
2-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-5,11-dimethyl-6-pyrimido[4,5-b][1,4]benzodiazepinone
N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]-4-[(3,5-dimethyl-4-isoxazolyl)methoxy]-3-methoxybenzamide
(2S)-2-[(4S,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-(3-methoxyphenyl)-4-methyl-5-[[methyl(pyridin-4-ylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
Pristinamycin IIA
A macrolide that is (together with pristinamycin IA) a component of pristinamycin, an oral streptogramin antibiotic produced by Streptomyces pristinaespiralis. Pristinamycin exhibits bactericidal activity against Gram positive organisms including methicillin-resistant Staphylococcus aureus.